NCT03746327View on ClinicalTrials.gov

Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

March 10, 2024

Conditions
Prostheses Infection
Interventions
DRUG

Sivextro 200 milligrams Oral Tablet

200 mg milligram per day during 4 weeks

Trial Locations (1)

Unknown

Laura Morata, Barcelona

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT03746327 - Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal | Biotech Hunter | Biotech Hunter